Your browser doesn't support javascript.
loading
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas.
Gil, Joan; Marques-Pamies, Montserrat; Jordà, Mireia; Fajardo-Montañana, Carmen; García-Martínez, Araceli; Sampedro, Miguel; Serra, Guillermo; Salinas, Isabel; Blanco, Alberto; Valassi, Elena; Sesmilo, Gemma; Carrato, Cristina; Cámara, Rosa; Lamas, Cristina; Casano-Sancho, Paula; Alvarez, Clara V; Bernabéu, Ignacio; Webb, Susan M; Picó, Antonio; Marazuela, Mónica; Puig-Domingo, Manel.
Afiliación
  • Gil J; Endocrine Research Unit, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
  • Marques-Pamies M; Department of Endocrinology and Nutrition, Germans Trias i Pujol University Hospital, Badalona, Spain.
  • Jordà M; Endocrine Research Unit, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
  • Fajardo-Montañana C; Department of Endocrinology, Hospital Universitario de La Ribera, Alzira, Spain.
  • García-Martínez A; Hospital General Universitario de Alicante-Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Sampedro M; Biomedical Research Networking Center in Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Serra G; Biomedical Research Networking Center in Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Salinas I; Department of Endocrinology and Nutrition, Hospital de la Princesa, Universidad Autónoma de Madrid, Instituto Princesa, Madrid, Spain.
  • Blanco A; Department of Endocrinology and Nutrition, Son Espases University Hospital, Palma de Mallorca, Spain.
  • Valassi E; Department of Endocrinology and Nutrition, Germans Trias i Pujol University Hospital, Badalona, Spain.
  • Sesmilo G; Department of Neurosurgery, Germans Trias i Pujol University Hospital, Badalona, Spain.
  • Carrato C; Department of Endocrinology/Medicine, CIBERER U747, ISCIII, Research Center for Pituitary Diseases, Hospital Sant Pau, IIB-SPau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Cámara R; Department of Endocrinology and Nutrition, Hospital Universitari Dexeus, Barcelona, Spain.
  • Lamas C; Department of Pathology, Germans Trias i Pujol University Hospital, Badalona, Spain.
  • Casano-Sancho P; Department of Endocrinology and Nutrition, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Alvarez CV; Department of Endocrinology and Nutrition, Hospital General Universitario de Albacete, Albacete, Spain.
  • Bernabéu I; Biomedical Research Networking Center in Rare Diseases (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Webb SM; Institut de Recerca Pediàtrica, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Spain.
  • Picó A; Neoplasia & Endocrine Differentiation P0L5, Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), University of Santiago de Compostela (USC), Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
  • Marazuela M; Department of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS)-SERGAS, Santiago de Compostela, Spain.
  • Puig-Domingo M; Department of Endocrinology/Medicine, CIBERER U747, ISCIII, Research Center for Pituitary Diseases, Hospital Sant Pau, IIB-SPau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Clin Endocrinol (Oxf) ; 94(5): 811-819, 2021 05.
Article en En | MEDLINE | ID: mdl-32978826

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Acromegalia / Adenoma Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Acromegalia / Adenoma Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2021 Tipo del documento: Article